Clinical trial · Interventional
Meridian Yoga on Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect in breast cancer patients with completion of chemotherapy, and that is characterized by associated clinical symptoms such as pain, tingling, numbness, and paresthesia etc. CIPN also interferes with patients' functions of daily living and leads to chronic functional decline and a reduced quality of life. Meridian yoga is beneficial to the treatment of patients with peripheral neuropathy and the improvement of their quality of life.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| CIPN - Chemotherapy-Induced Peripheral Neuropathy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| yoga | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- meridian yoga
- description
- 60 minutes yoga ,twice a week for 8 weeks
- interventionNames
- Other: yoga
- type
- NO_INTERVENTION
- label
- usual care group
- description
- 8 weeks of general care
Primary outcomes (1)
- measure
- Neuropathic Pain Scale
- timeFrame
- Change from baseline of Neuropathic Pain Scale at 8 weeks.
- description
- The questionnaire explores the performance of patients with neuropathic pain and nociceptive pain in different pain types in this questionnaire, and has appropriate reliability and validity, among which, specific pain performance, for different types of pain and changes in nerve conduction examination have special performance. This questionnaire is NPSI-T(Chinese version of neuropathic pain symptom inventory). It consists of 12 questions, all of which address pain on a scale of 0-10. Higher scores mean a worse outcome.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Chinese or Taiwanese-proficient men and women aged ≥18 years. 2. Patients with stage I-III breast cancer. 3. Suffering from peripheral neuropathy caused by chemotherapy (professional judgment by a physician). 4. Willing to adhere to requirement that no new pain medication be taken throughout the study period. 5. Willing to adhere to all study-related procedures, including randomization to one of the two arms. 6. Patient answers "Yes" to at least one factor in the question: "Do participants think your balance, gait, posture, alignment, or flexibility has been affected by your experience of CIPN?" Exclusion Criteria: 1. Metastatic disease. 2. Drugs abuse such as amphetamines, morphine, etc. 3. Pregnant 4. Those with severe mental illness or mental instability who cannot cooperate with the trial. 5. People who are severely hearing impaired, visually impaired, or demented and unable to perform yoga. 6. Severe heart disease or chronic obstructive lung disease, liver or kidney failure,and edema or severe skin damage. 7. Severe spinal disease, affecting actors. 8. Those who have participated in yoga practice in the past month. 9. Those who do not sign the informed consent.
References
Publications (0)
Data not yet available